These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

508 related items for PubMed ID: 8602631

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. [Physiopathology and therapy of hemophilia and von Willebrand's disease].
    Fukui H.
    Nihon Naika Gakkai Zasshi; 1991 Jun 10; 80(6):866-74. PubMed ID: 1919201
    [No Abstract] [Full Text] [Related]

  • 25. Expression of two type 2N von Willebrand disease mutations identified in exon 18 of von Willebrand factor gene.
    Hilbert L, Jorieux S, Fontenay-Roupie M, Guicheteau M, Fressinaud E, Meyer D, Mazurier C, INSERM Network on Molecular Abnormalities in von Willebrand Disease.
    Br J Haematol; 2004 Oct 10; 127(2):184-9. PubMed ID: 15461624
    [Abstract] [Full Text] [Related]

  • 26. Molecular mechanism and classification of von Willebrand disease.
    Sadler JE, Matsushita T, Dong Z, Tuley EA, Westfield LA.
    Thromb Haemost; 1995 Jul 10; 74(1):161-6. PubMed ID: 8578450
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Identification of a new type 2M von Willebrand disease mutation also at position 1324 of von Willebrand factor.
    Hilbert L, Fressinaud E, Ribba AS, Meyer D, Mazurier C, INSERM network on molecular abnormalities in von Willebrand disease.
    Thromb Haemost; 2002 Apr 10; 87(4):635-40. PubMed ID: 12008946
    [Abstract] [Full Text] [Related]

  • 30. [Hemostatic effect of deamino-8-D-arginine vasopressin (DDAVP) in hemophilia A and von Willebrand's disease].
    Fukui H, Takase T.
    Rinsho Ketsueki; 1985 Jul 10; 26(7):1069-79. PubMed ID: 3932720
    [No Abstract] [Full Text] [Related]

  • 31. Laboratory diagnosis and molecular classification of von Willebrand disease.
    Gadisseur A, Hermans C, Berneman Z, Schroyens W, Deckmyn H, Michiels JJ.
    Acta Haematol; 2009 Jul 10; 121(2-3):71-84. PubMed ID: 19506352
    [Abstract] [Full Text] [Related]

  • 32. Ser968Thr mutation within the A3 domain of von Willebrand factor (VWF) in two related patients leads to a defective binding of VWF to collagen.
    Ribba AS, Loisel I, Lavergne JM, Juhan-Vague I, Obert B, Cherel G, Meyer D, Girma JP.
    Thromb Haemost; 2001 Sep 10; 86(3):848-54. PubMed ID: 11583318
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. von Willebrand disease: from the bedside to therapy.
    Aledort LM.
    Thromb Haemost; 1997 Jul 10; 78(1):562-5. PubMed ID: 9198216
    [Abstract] [Full Text] [Related]

  • 35. An Arg760Cys mutation in the consensus sequence of the von Willebrand factor propeptide cleavage site is responsible for a new von Willebrand disease variant.
    Casonato A, Sartorello F, Cattini MG, Pontara E, Soldera C, Bertomoro A, Girolami A.
    Blood; 2003 Jan 01; 101(1):151-6. PubMed ID: 12393698
    [Abstract] [Full Text] [Related]

  • 36. Identification of von Willebrand disease type 2N (Normandy) in Australia: a cross-laboratory investigation using different methods.
    Rodgers SE, Lerda NV, Favaloro EJ, Duncan EM, Casey GJ, Quinn DM, Hertzberg M, Lloyd JV.
    Am J Clin Pathol; 2002 Aug 01; 118(2):269-76. PubMed ID: 12162689
    [Abstract] [Full Text] [Related]

  • 37. Von Willebrand factor and von Willebrand's disease: a complex protein and a complex disease.
    Bona RD.
    Ann Clin Lab Sci; 1989 Aug 01; 19(3):184-9. PubMed ID: 2499240
    [Abstract] [Full Text] [Related]

  • 38. Managing patients with von Willebrand disease type 1, 2 and 3 with desmopressin and von Willebrand factor-factor VIII concentrate in surgical settings.
    Michiels JJ, van Vliet HH, Berneman Z, Schroyens W, Gadisseur A.
    Acta Haematol; 2009 Aug 01; 121(2-3):167-76. PubMed ID: 19506363
    [Abstract] [Full Text] [Related]

  • 39. [Von Willebrand disease--type 2N (case report)].
    Zarnovicanová M, Pelikánová S.
    Vnitr Lek; 2003 Apr 01; 49(4):319-21. PubMed ID: 12793057
    [Abstract] [Full Text] [Related]

  • 40. Inactivation of human factor VIII by activated protein C. Cofactor activity of protein S and protective effect of von Willebrand factor.
    Koedam JA, Meijers JC, Sixma JJ, Bouma BN.
    J Clin Invest; 1988 Oct 01; 82(4):1236-43. PubMed ID: 2971673
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 26.